SCHEMBL19964497

SCHEMBL19964497

Nc1cnc(Br)cc1NNc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ CTSD P07339 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ EGFR P00533 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ATR Q13535 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.35
▸ GAA P10253 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ALK Q9UM73 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4004912 0.85 MAPT (0.48) ALDH1A1TDP1EGFRMAPTLMNA
SCHEMBL30711414 0.71 UHRF1 (0.39) EGFRKMT2AHTT
SCHEMBL1584807 0.71 UHRF1 (0.39) EGFRKMT2AHTT
SCHEMBL19964834 0.70 SIRT2 (0.56) NPC1RAB9AATRMEN1KMT2A
Hydrochloric Acid SCHEMBL20266526 0.69 UHRF1 (0.38) EGFR
SCHEMBL19243778 0.69 GAA (0.49) ALDH1A1TDP1EGFRMAPTSMN1; SMN2
SCHEMBL29831973 0.68 MAPT (0.64) ALDH1A1CTSDTDP1MAPTLMNA
SCHEMBL9222331 0.68 MAPT (0.64) ALDH1A1CTSDTDP1MAPTLMNA
SCHEMBL15286061 0.66 KDM4E (0.47) ALDH1A1EGFRMAPTLMNASMN1; SMN2
SCHEMBL16217238 0.66 ALDH1A1 (0.52) ALDH1A1CTSDTDP1EGFRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048930-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 — — WO disclosed
Send feedback